| Primary |
| Product Used For Unknown Indication |
50.0% |
| Weight Control |
50.0% |
|
| Condition Aggravated |
50.0% |
| Psychomotor Hyperactivity |
50.0% |
|
| Secondary |
| Ill-defined Disorder |
40.0% |
| Parenteral Nutrition |
25.0% |
| Drug Use For Unknown Indication |
18.3% |
| Blood Lactate Dehydrogenase Abnormal |
6.7% |
| Ovarian Cancer |
5.0% |
| Bipolar Disorder |
1.7% |
| Drug Exposure During Pregnancy |
1.7% |
| Multiple Myeloma |
1.7% |
|
| Prophylaxis Of Nausea And Vomiting |
33.3% |
| Hypercalcaemia |
22.2% |
| Ammonia Increased |
11.1% |
| Rectal Haemorrhage |
11.1% |
| Ventricular Septal Defect |
11.1% |
| Viith Nerve Paralysis |
11.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.7% |
| Product Used For Unknown Indication |
30.7% |
| Multiple Myeloma |
5.2% |
| Hypertension |
3.5% |
| Supplementation Therapy |
3.2% |
| Pain |
2.6% |
| Medical Diet |
2.5% |
| Vitamin Supplementation |
2.5% |
| Convulsion |
2.0% |
| Peripheral Sensory Neuropathy |
2.0% |
| Abdominal Pain |
1.9% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Nephrogenic Anaemia |
1.8% |
| Hepatic Neoplasm Malignant |
1.7% |
| Prophylaxis |
1.7% |
| Cardiac Disorder |
1.2% |
| Osteoporosis |
1.2% |
| Blood Cholesterol Increased |
1.1% |
| Dialysis |
1.0% |
| Diarrhoea |
1.0% |
|
| Death |
7.1% |
| Pneumonia |
7.1% |
| Reticulocyte Count Decreased |
7.1% |
| Troponin Increased |
7.1% |
| Upper Gastrointestinal Haemorrhage |
7.1% |
| Weight Increased |
7.1% |
| Back Pain |
4.8% |
| Duodenal Ulcer |
4.8% |
| Pain |
4.8% |
| Thrombocytopenia |
4.8% |
| Ventricular Extrasystoles |
4.8% |
| Vomiting |
4.8% |
| Blood Cholesterol Increased |
3.6% |
| Dehydration |
3.6% |
| Drug Ineffective |
3.6% |
| Dysgeusia |
3.6% |
| Fatigue |
3.6% |
| Headache |
3.6% |
| Hepatotoxicity |
3.6% |
| International Normalised Ratio Increased |
3.6% |
|
| Interacting |
| Asthenia |
75.0% |
| Bipolar I Disorder |
25.0% |
|
|
